What is the equity of Polynovo this year?
Polynovo has equity of 72.12 M AUD this year.
Polynovo Equity 2025
Polynovo Equity
72.12 M AUD
Ticker
PNV.AX
ISIN
AU000000PNV0
WKN
A12F4T
In 2025, Polynovo's equity was 72.12 M AUD, a 10.31% increase from the 65.38 M AUD equity in the previous year.
Polynovo Aktienanalyse
What does Polynovo do?
Polynovo Ltd is an Australian BioTech company that specializes in the development and manufacturing of medical implants. The company was founded in 1986 under the name Regeneus Ltd and is headquartered in Melbourne. Polynovo's history began with the development of products for the veterinary field. In 2000, the company received approval for the sale of its first human products, which were used for wound treatment. In 2014, the company was renamed Polynovo to emphasize its focus on biological implants for human tissue. Polynovo utilizes a revolutionary technology called NovoSorb, which allows for the production of biodegradable polymer films in various shapes and sizes. These are then used as implants in the human body and naturally degrade within a predetermined timeframe. Polynovo is divided into various divisions, including wound care, plastic surgery, and orthopedics. In wound care, the company offers products that aim to prevent infections and promote natural healing processes. The plastic surgery division provides implants for breast reconstruction and fat transplantation. In orthopedics, Polynovo manufactures implants for joints, bones, and tendons. An example of a Polynovo product is NovoSorb BTM (Biodegradable Temporary Matrix), which is used in burns and other skin defects. The matrix stimulates healing and the formation of new tissue, restoring a normal appearance to the patient. Polynovo's business model is based on long-term relationships with hospitals, medical professionals, and government agencies. The company heavily invests in research and development to continuously improve and expand its technology and product range. Through partnerships with other companies and academic institutions, Polynovo is working towards global distribution of its products. Overall, Polynovo has received various awards over the years, including an innovation award from the Australian Trade Commission, and has been recognized multiple times as one of Australia's fastest-growing companies. In conclusion, Polynovo is an innovative and successful company specializing in the development and manufacturing of biological implants. Thanks to its NovoSorb technology, the company can offer products that help accelerate the healing process and facilitate faster patient recovery. Polynovo ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Polynovo's Equity
Polynovo's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Polynovo's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Polynovo's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Polynovo's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Polynovo’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Polynovo stock
What was the equity of Polynovo compared to the previous year?
The equity of Polynovo has increased/decreased by 10.31% increased compared to the previous year.
What impact does a high equity have on investors of Polynovo?
A high equity is advantageous for investors of Polynovo as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Polynovo?
A low equity can be a risk for investors of Polynovo, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Polynovo affect the company?
An increase in equity of Polynovo can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Polynovo affect the company?
A reduction in equity of Polynovo can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Polynovo?
Some factors that can affect the equity of Polynovo include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Polynovo so important for investors?
The equity of Polynovo is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Polynovo take to change the equity?
To change equity, Polynovo can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Polynovo pay?
Over the past 12 months, Polynovo paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Polynovo is expected to pay a dividend of 0 AUD.
What is the dividend yield of Polynovo?
The current dividend yield of Polynovo is .
When does Polynovo pay dividends?
Polynovo pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Polynovo?
Polynovo paid dividends every year for the past 0 years.
What is the dividend of Polynovo?
For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Polynovo located?
Polynovo is assigned to the 'Health' sector.
Wann musste ich die Aktien von Polynovo kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Polynovo from 8/25/2025 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 8/25/2025.
When did Polynovo pay the last dividend?
The last dividend was paid out on 8/25/2025.
What was the dividend of Polynovo in the year 2024?
In the year 2024, Polynovo distributed 0 AUD as dividends.
In which currency does Polynovo pay out the dividend?
The dividends of Polynovo are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Polynovo
Our stock analysis for Polynovo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Polynovo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
